
Profitability, historical returns, and peer comparisons.
According to ImmunityBio, Inc.’s latest financial reports and current stock price. The company's current ROE is 134.99%. This represents a change of 350.08% compared to the average of 29.99% of the last 4 quarters.
The mean historical ROE of ImmunityBio, Inc. over the last ten years is 47.01%. The current 134.99% ROE has changed 187.16% with respect to the historical average. Over the past ten years (40 quarters), IBRX's ROE was at its highest in in the March 2026 quarter at 72.73%. The ROE was at its lowest in in the March 2020 quarter at -36.10%.
Average
47.01%
Median
77.45%
Minimum
-65.91%
Maximum
185.17%
Discovering the peaks and valleys of ImmunityBio, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 49.58%
Maximum Annual ROE = 185.17%
Minimum Annual Increase = -439.67%
Minimum Annual ROE = -65.91%
| Year | ROE | Change |
|---|---|---|
| 2025 | 70.34% | -16.81% |
| 2024 | 84.56% | -14.89% |
| 2023 | 99.35% | 6.69% |
| 2022 | 93.12% | -34.97% |
| 2021 | 143.20% | -22.67% |
| 2020 | 185.17% | -439.67% |
| 2019 | -54.52% | -17.28% |
| 2018 | -65.91% | 49.58% |
| 2017 | -44.06% | 7.01% |
| 2016 | -41.17% | -38.12% |
The current ROE of ImmunityBio, Inc. (IBRX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
84.75%
5-year avg
98.11%
10-year avg
47.01%
ImmunityBio, Inc.’s ROE is greater than Immunocore Holdings plc (-2.35%), greater than BioNTech SE (-9.16%), greater than Iovance Biotherapeutics, Inc. (-40.51%), greater than Vir Biotechnology, Inc. (-21.38%), greater than Moderna, Inc. (-39.20%), greater than Legend Biotech Corporation (-8.70%), greater than Nkarta, Inc. (-39.64%), greater than Immatics N.V. (-47.04%), less than Atara Biotherapeutics, Inc. (44.67%), greater than Allogene Therapeutics, Inc. (-50.04%),
| Company | ROE | Market cap |
|---|---|---|
| -2.35% | $1.51B | |
| -9.16% | $22.10B | |
| -40.51% | $3.94B | |
| -21.38% | $1.99B | |
| -39.20% | $103.15B | |
| -8.70% | $4.21B | |
| -39.64% | $123.91M | |
| -47.04% | $1.03B | |
| 44.67% | $84.02M | |
| -50.04% | $411.13M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ImmunityBio, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like ImmunityBio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is ImmunityBio, Inc.'s ROE?
How is the ROE calculated for ImmunityBio, Inc. (IBRX)?
What is the highest ROE for ImmunityBio, Inc. (IBRX)?
What is the 3-year average ROE for ImmunityBio, Inc. (IBRX)?
What is the 5-year average ROE for ImmunityBio, Inc. (IBRX)?
How does the current ROE for ImmunityBio, Inc. (IBRX) compare to its historical average?